Moreno Eva, Andreu Antonia, Pigrau Carles, Kuskowski Michael A, Johnson James R, Prats Guillem
Microbiology Department, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
J Clin Microbiol. 2008 Aug;46(8):2529-34. doi: 10.1128/JCM.00813-08. Epub 2008 May 21.
Previous epidemiological assessments of the prevalence versus special-pathogenicity hypothesis for urinary tract infection (UTI) pathogenesis in women may have been confounded by underlying host population differences between women with UTI and healthy controls and have not considered the clonal complexity of the fecal Escherichia coli population of the host. In the present study, 42 women with acute uncomplicated cystitis served as their own controls for an analysis of the causative E. coli strain and the concurrent intestinal E. coli population. Clonality among the urine isolate and 30 fecal colonies per subject was assessed by repetitive-element PCR and macrorestriction analysis. Each unique clone underwent PCR-based phylotyping and virulence genotyping. Molecular analysis resolved 109 unique clones (4 urine-only, 38 urine-fecal, and 67 fecal-only clones). Urine clones exhibited a significantly higher prevalence of group B2 than fecal-only clones (69% versus 10%; P < 0.001) and higher aggregate virulence scores (mean, 6.2 versus 2.9; P < 0.001). In multilevel regression models for predicting urine clone status, significant positive predictors included group B2, 10 individual virulence traits, the aggregate virulence score, fecal dominance, relative fecal abundance, and (unique to the present study) a pauciclonal fecal sample. In summary, within the fecal E. coli populations of women with acute cystitis, pauciclonality, clonal dominance, virulence, and group B2 status are closely intertwined. Phylogenetic group B2 status and/or associated virulence factors may promote fecal abundance and pauciclonality, thereby contributing to upstream steps in UTI pathogenesis. This relationship suggests a possible reconciliation of the prevalence and special-pathogenicity hypotheses.
先前针对女性尿路感染(UTI)发病机制的患病率与特殊致病性假说进行的流行病学评估,可能因UTI女性患者与健康对照人群之间潜在的宿主群体差异而产生混淆,并且未考虑宿主粪便大肠杆菌群体的克隆复杂性。在本研究中,42名患有急性单纯性膀胱炎的女性作为自身对照,用于分析致病性大肠杆菌菌株和同时存在的肠道大肠杆菌群体。通过重复元件PCR和宏观限制性分析评估每个受试者尿液分离株和30个粪便菌落之间的克隆性。每个独特的克隆都进行基于PCR的系统发育分型和毒力基因分型。分子分析解析出109个独特的克隆(4个仅尿液中的克隆、38个尿液-粪便中的克隆和67个仅粪便中的克隆)。尿液克隆中B2组的患病率显著高于仅粪便中的克隆(69%对10%;P<0.001),且总体毒力得分更高(平均值分别为6.2和2.9;P<0.001)。在预测尿液克隆状态的多水平回归模型中,显著的阳性预测因素包括B2组、10个个体毒力特征、总体毒力得分、粪便优势度、相对粪便丰度以及(本研究独有的)寡克隆粪便样本。总之,在患有急性膀胱炎的女性粪便大肠杆菌群体中,寡克隆性、克隆优势度、毒力和B2组状态紧密相连。系统发育B2组状态和/或相关毒力因子可能促进粪便丰度和寡克隆性,从而促成UTI发病机制中的上游步骤。这种关系表明患病率假说和特殊致病性假说可能达成和解。